You are here:

MS in the media - 25 August 2017

Published on

19 - 25 August 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Are we close to a cure?

Article attempts to answer this question by picking out recent research including ocrelizumab, laquinimod, stem cells, biotin, siponimod, resistance training, antioxidants and gut microbes.

Source: Medical News Today

MS Trust link: Research updates
MS Trust link: Drugs in development

Raising the profile of horse riding for the disabled

Anne Brown who has SPMS will be celebrating her 60th birthday year with a series of fundraising challenges for a Scottish horse riding for the disabled charity.

Source: Falkirk Herald

MS Trust link: Hippotherapy

Cladribine (Mavenclad) gets European licence for highly active relapsing MS

The European Commission has granted cladribine (Mavenclad) a marketing authorization for the treatment of highly active relapsing MS.  This follows an earlier recommendation from the European Medicines Agency.

Source: Merck press release
Source: Pharmatimes

MS Trust link: Cladribine gets European licence

Print this page